KNSA
Kiniksa Pharmaceuticals International plc. - Class A
$74.34
-4.94% ($3.86)
Volume
1.03M
52W High
$82.94
52W Low
$29.90
Market Cap
$5.93B
What to Watch This Quarter
Based on historical dataConsensus EPS
$0.30
Whisper EPS
$0.30
0.4% below consensus
Last Quarter
$0.30
Current Streak
1 Meet
Avg Surprise (4Q)
-8.33%
Next Earnings Report
Reports in 2 days
Price Chart
EPS History: Consensus vs Actual
Last 12 quartersPrice Movement Around Earnings
Q2 2026
Jul 28, 2026
1-Day:
+1.86%
Q1 2026
May 5, 2026
1-Day:
+2.63%
Q1 2026
Apr 28, 2026
1-Day:
-1.60%
Q4 2025
Mar 3, 2026
1-Day:
+4.19%
Revenue & Financial Performance
| Quarter | Revenue | YoY Growth | Gross Margin | Op Margin | Net Income |
|---|---|---|---|---|---|
| Q4'25 | $202.1M | +65.0% | 54.9% | 9.8% | $14.2M |
| Q3'25 | $180.9M | +61.2% | 53.8% | 13.3% | $18.4M |
| Q2'25 | $156.8M | +44.3% | 54.7% | 12.9% | $17.8M |
| Q1'25 | $137.8M | +72.5% | 55.3% | 9.6% | $8.5M |
| Q4'24 | $122.5M | +46.9% | 46.0% | -15.8% | -$8.9M |
| Q3'24 | $112.2M | +67.4% | 56.0% | -8.6% | -$12.7M |
| Q2'24 | $108.6M | +52.0% | 60.9% | -0.1% | -$3.9M |
| Q1'24 | $79.9M | +65.2% | 60.5% | -20.7% | -$17.7M |
Company Information
Symbol
KNSA
Company
Kiniksa Pharmaceuticals International plc. - Class A
Market Cap
$5.93B
Next Earnings
Aug 4, 2026